MARKER THERAPEUTICS, INC. — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/48be8d02-aec8-4ef2-91ba-7b2968226e02/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-12.9M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-031274 |
| FY 2024 | $-11.1M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000549 |
| FY 2023 | $-14.6M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-000297 |
| FY 2022 | $-19.8M | 2022-01-01 – 2022-12-31 | evidence 0001410578-24-000297 |
| FY 2021 | $-39.5M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000418 |
| FY 2020 | $-28.9M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-033855 |
| FY 2019 | $-22.5M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-032463 |
| FY 2018 | $-148.2M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-014350 |
| FY 2017 | $-11.5M | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-014350 |
| FY 2016 | $-8.5M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-014490 |
| FY 2015 | $-6.2M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-541539 |
| FY 2014 | $-3.4M | 2014-01-01 – 2014-12-31 | evidence 0001424884-15-000039 |
| FY 2013 | $-2.7M | 2013-01-01 – 2013-12-31 | evidence 0001424884-15-000039 |
| FY 2012 | $-42.6M | 1999-07-27 – 2013-03-31 | evidence 0001424884-13-000037 |
| FY 2011 | $-35.9M | 1999-07-27 – 2012-03-31 | evidence 0001424884-12-000038 |
| FY 2010 | $-5.5M | 2010-01-01 – 2010-12-31 | evidence 0001424884-12-000026 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MARKER THERAPEUTICS, INC. — all facts · Revenue · Net Income